Researchers Identify Possible Cause of Chronic Pain in Parkinson’s Patients
source: pixabay.com

Researchers Identify Possible Cause of Chronic Pain in Parkinson’s Patients

Chronic pain affects about two-thirds of those with Parkinson's, making it the major non-motor symptom of the disease. A study published in Movements Disorders has found that anandamide and glucocerebroside…

Continue Reading Researchers Identify Possible Cause of Chronic Pain in Parkinson’s Patients
ICYMI: Recurrent Respiratory Papillomatosis Treatment Receives Orphan Drug Designation
source: pixabay.com

ICYMI: Recurrent Respiratory Papillomatosis Treatment Receives Orphan Drug Designation

INO-3107, a treatment for recurrent respiratory papillomatosis (RRP), has recently received the Orphan Drug Designation from the FDA. This treatment is currently being evaluate in a Phase 1/2 trial by…

Continue Reading ICYMI: Recurrent Respiratory Papillomatosis Treatment Receives Orphan Drug Designation
Studies from UCSF Offer New Perspective on Fibromyalgia and Chronic Fatigue Syndrome
source: pixabay.com

Studies from UCSF Offer New Perspective on Fibromyalgia and Chronic Fatigue Syndrome

  Researchers discovered surprising results after performing new studies of chronic fatigue syndrome (ME/CFS) and fibromyalgia (FM). According to a report by Cort Johnson in HealthRising, the new studies give…

Continue Reading Studies from UCSF Offer New Perspective on Fibromyalgia and Chronic Fatigue Syndrome
Rare Pediatric Disease Designation Given for Investigative Lymphatic Malformations Therapy
source: pixabay.com

Rare Pediatric Disease Designation Given for Investigative Lymphatic Malformations Therapy

Rare Pediatric Disease Designation has just been granted by the FDA for an investigative therapy for lymphatic malformations (LMs). This therapy is called TARA-002 and was developed by Protara Therapeutics.…

Continue Reading Rare Pediatric Disease Designation Given for Investigative Lymphatic Malformations Therapy
Nipocalimab is Making Progress in Four Clinical Trials for Autoimmune and Alloimmune Conditions
source: pixabay.com

Nipocalimab is Making Progress in Four Clinical Trials for Autoimmune and Alloimmune Conditions

An investigative therapy for hemolytic disease of the fetus and newborn (HDFN) has just received the FDA's Rare Pediatric Disease and Orphan Drug Designations. This therapy is called nipocalimab and…

Continue Reading Nipocalimab is Making Progress in Four Clinical Trials for Autoimmune and Alloimmune Conditions
Close Menu